Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non-small cell lung cancer
Poon, Candice C., Kelly, John J.Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.30533
Date:
November, 2016
File:
PDF, 1.33 MB
english, 2016